[Sdudy on effect of tripterygium on plasma IL-18 content in patients with lupus nephritis].
It is to study the effect of tripterygium (TW) on the plasma IL-18 content in patients with lupus nephritis (LN) and its treatment value. The patients with LN treated with prednisone were divided into active groupand inactive group with active index. The active group was given tripterygium additionally. The changing of plasma IL-18 and release of nephritis were observed after treatment for three months. The level of plasma IL-18 lowered down obviously, urinary protein decreased, LN activity index, hematuria and renal function improved. Tripterygium caninhibitroduction of plasma IL-18. It has definite treatment value on controlling LN activity.